| Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge B Raman, MP Cassar, EM Tunnicliffe, N Filippini, L Griffanti, ... EClinicalMedicine 31, 2021 | 635 | 2021 |
| Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study RA Evans, H McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ... The Lancet Respiratory Medicine 9 (11), 1275-1287, 2021 | 465 | 2021 |
| Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ... The Lancet Respiratory Medicine 10 (8), 761-775, 2022 | 283 | 2022 |
| Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis JB Badenoch, ER Rengasamy, C Watson, K Jansen, S Chakraborty, ... Brain communications 4 (1), fcab297, 2022 | 192 | 2022 |
| Neurology and neuropsychiatry of COVID-19: a systematic review and meta-analysis of the early literature reveals frequent CNS manifestations and key emerging narratives JP Rogers, CJ Watson, J Badenoch, B Cross, M Butler, J Song, D Hafeez, ... Journal of Neurology, Neurosurgery & Psychiatry 92 (9), 932-941, 2021 | 141 | 2021 |
| Neurobiological basis of motivational deficits in psychopathology JD Salamone, I Koychev, M Correa, P McGuire European Neuropsychopharmacology 25 (8), 1225-1238, 2015 | 96 | 2015 |
| Visual information processing deficits as biomarkers of vulnerability to schizophrenia: an event-related potential study in schizotypy I Koychev, W El-Deredy, C Haenschel, JFW Deakin Neuropsychologia 48 (7), 2205-2214, 2010 | 95 | 2010 |
| PET tau and amyloid-β burden in mild Alzheimer’s disease: divergent relationship with age, cognition, and cerebrospinal fluid biomarkers I Koychev, RN Gunn, A Firouzian, J Lawson, G Zamboni, B Ridha, ... Journal of Alzheimer's Disease 60 (1), 283-293, 2017 | 79 | 2017 |
| Cognitive–behavioural therapy for non-motor symptoms of Parkinson's disease: a clinical review I Koychev, D Okai BMJ Ment Health 20 (1), 15-20, 2017 | 66 | 2017 |
| A validation of cognitive biomarkers for the early identification of cognitive enhancing agents in schizotypy: a three-center double-blind placebo-controlled study I Koychev, K McMullen, J Lees, R Dadhiwala, L Grayson, C Perry, ... European Neuropsychopharmacology 22 (7), 469-481, 2012 | 63 | 2012 |
| SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination F Liew, S Talwar, A Cross, BJ Willett, S Scott, N Logan, MK Siggins, ... EBioMedicine 87, 2023 | 58 | 2023 |
| The dementias platform UK (DPUK) data portal S Bauermeister, C Orton, S Thompson, RA Barker, JR Bauermeister, ... European journal of epidemiology 35, 601-611, 2020 | 53 | 2020 |
| Gait in mild Alzheimer’s disease: feasibility of multi-center measurement in the clinic and home with body-worn sensors: a pilot study R Mc Ardle, R Morris, A Hickey, S Del Din, I Koychev, RN Gunn, J Lawson, ... Journal of Alzheimer's disease 63 (1), 331-341, 2018 | 53 | 2018 |
| Nightmares and suicide: predicting risk in depression P Marinova, I Koychev, L Laleva, L Kancheva, M Tsvetkov, R Bilyukov, ... Psychiatria Danubina 26 (2), 0-164, 2014 | 53 | 2014 |
| Digital technologies for the assessment of cognition: a clinical review A Chinner, J Blane, C Lancaster, C Hinds, I Koychev BMJ Ment Health 21 (2), 67-71, 2018 | 41 | 2018 |
| Effects of risperidone, amisulpride and nicotine on eye movement control and their modulation by schizotypy A Schmechtig, J Lees, L Grayson, KJ Craig, R Dadhiwala, GR Dawson, ... Psychopharmacology 227, 331-345, 2013 | 40 | 2013 |
| Evaluating the feasibility of frequent cognitive assessment using the Mezurio smartphone app: observational and interview study in adults with elevated dementia risk C Lancaster, I Koychev, J Blane, A Chinner, L Wolters, C Hinds JMIR mHealth and uHealth 8 (4), e16142, 2020 | 38 | 2020 |
| Remote monitoring technologies in Alzheimer’s disease: design of the RADAR-AD study M Muurling, C de Boer, R Kozak, D Religa, I Koychev, H Verheij, ... Alzheimer's research & therapy 13 (1), 89, 2021 | 36 | 2021 |
| The effect of sodium nitroprusside on psychotic symptoms and spatial working memory in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial JM Stone, PD Morrison, I Koychev, F Gao, TJ Reilly, M Kolanko, ... Psychological medicine 46 (16), 3443-3450, 2016 | 36 | 2016 |
| Blood-based ATN biomarkers of Alzheimer’s disease: a meta-analysis I Koychev, K Jansen, A Dette, L Shi, H Holling Journal of Alzheimer's Disease 79 (1), 177-195, 2021 | 35 | 2021 |
